IL133882A0 - Process for making an intranasal drug delivery system - Google Patents

Process for making an intranasal drug delivery system

Info

Publication number
IL133882A0
IL133882A0 IL13388298A IL13388298A IL133882A0 IL 133882 A0 IL133882 A0 IL 133882A0 IL 13388298 A IL13388298 A IL 13388298A IL 13388298 A IL13388298 A IL 13388298A IL 133882 A0 IL133882 A0 IL 133882A0
Authority
IL
Israel
Prior art keywords
making
delivery system
drug delivery
intranasal drug
intranasal
Prior art date
Application number
IL13388298A
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL133882A0 publication Critical patent/IL133882A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
IL13388298A 1997-07-18 1998-07-17 Process for making an intranasal drug delivery system IL133882A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5296497P 1997-07-18 1997-07-18
US5662597P 1997-08-20 1997-08-20
US94240397A 1997-10-01 1997-10-01
PCT/US1998/014790 WO1999003452A1 (en) 1997-07-18 1998-07-17 Methods of removing residual solvent from nasal drug delivery compositions

Publications (1)

Publication Number Publication Date
IL133882A0 true IL133882A0 (en) 2001-04-30

Family

ID=27368315

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13388298A IL133882A0 (en) 1997-07-18 1998-07-17 Process for making an intranasal drug delivery system

Country Status (6)

Country Link
EP (1) EP0994700A4 (en)
JP (1) JP2001510150A (en)
AU (1) AU747211B2 (en)
CA (1) CA2296620A1 (en)
IL (1) IL133882A0 (en)
WO (1) WO1999003452A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1243247A1 (en) * 2001-03-22 2002-09-25 Cognis Iberia, S.L. Emulsions of the type W/O or O/W/O comprising microcapsules consisting of active agents and thermogelling heteropolysaccharides or proteins
US20040146564A1 (en) * 2001-04-05 2004-07-29 Muriel Subirade Process for making delivery matrix and uses thereof
EP1430947A1 (en) * 2002-12-21 2004-06-23 Cognis Iberia, S.L. Multicompartment microparticles with liquid crystalline cores
US8017152B2 (en) 2005-05-27 2011-09-13 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
EP1726299A3 (en) * 2005-05-27 2007-04-18 StratoSphere Pharma AB Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
CN102716469B (en) * 2012-07-07 2013-09-11 北京三元基因工程有限公司 Dry powder inhalant of interferon alpha
KR101738127B1 (en) * 2014-08-08 2017-05-22 (주)비씨월드제약 A method for producing drug-containing sustained release micro particle

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3578498A (en) * 1967-06-12 1971-05-11 Cpc International Inc Desolventizing of starch
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
CA2094217A1 (en) * 1992-04-17 1993-10-18 Yasutaka Igari Transmucosal therapeutic composition
GB9414966D0 (en) * 1994-07-26 1994-09-14 Danbiosyst Uk Pharmaceutical compositions for the nasal administration of antiviral agents

Also Published As

Publication number Publication date
AU8493598A (en) 1999-02-10
CA2296620A1 (en) 1999-01-28
EP0994700A4 (en) 2000-10-18
JP2001510150A (en) 2001-07-31
WO1999003452A9 (en) 1999-04-29
WO1999003452A1 (en) 1999-01-28
AU747211B2 (en) 2002-05-09
EP0994700A1 (en) 2000-04-26

Similar Documents

Publication Publication Date Title
SG80049A1 (en) Delivery system
PL348205A1 (en) System for supplying an inhalable aerosol
IL136774A0 (en) Medication delivery apparatus
EP1061987A4 (en) Drug delivery system
EP0989878A4 (en) Drug delivery system
EP1225941A4 (en) Intranasal delivery system
AU7201998A (en) Drug delivery system
SG79983A1 (en) Conveying system
EP1021137A4 (en) Drug delivery system
GB9721367D0 (en) Delivery system
IL133882A0 (en) Process for making an intranasal drug delivery system
EP1019359A4 (en) Process for preparing aminoarylacetylenes
EG23935A (en) Process for preparing eprosartin
EG22077A (en) Process for preparing 4-substituted-ih-indole-3 glyoxamides
EP0913159A4 (en) Drug delivery system using galactoxyloglucan
IL126184A (en) Process for preparing pentafluoropentanol
AU135396S (en) Medication delivery apparatus
GB2323186B (en) Check system for production process procedure
GB2323069B (en) Conveying apparatus
SG67570A1 (en) Conveying apparatus
IL125646A0 (en) Process for preparing n-pyruvyl-l-proline
GB2337520B (en) Delivery system
GB9600471D0 (en) Drug delivery system
GB9718271D0 (en) Gene delivery system
GB9718273D0 (en) Gene delivery system